What Posos does

Posos is a French medtech company headquartered in Amiens that operates a CE Class IIb certified clinical decision support platform designed to optimize medication prescribing for healthcare professionals across the patient journey. The platform combines a proprietary medical knowledge graph, hybrid natural language processing (NER/L, ML), computer vision for prescription scanning, and a multilingual, HAS-agrément drug database built from 220+ official sources and 100,000+ medical documents. Posos positions itself as the only certified plug-and-play software infrastructure that takes raw patient data (text, voice, scanned/PDF prescriptions) and produces normalized SNOMED-CT / FHIR / ICD-10/11 structured outputs and personalized prescription recommendations via GraphQL, FHIR, and CDS Hooks APIs.

The company monetizes through four streams: a freemium individual practitioner subscription (free basic tier, paid premium with 3-month trial, billed annually via Stripe), B2B API licensing to medical software editors who embed Posos into their EHR/LAP solutions (quote-based, multi-year), enterprise contracts with hospitals and healthcare establishments (quote-based, multi-year, including onboarding and training), and professional services. Go-to-market combines API-first OEM embedding (primary), direct enterprise field sales to hospitals, self-serve B2C via iOS/Android apps, channel partnerships with pharmacy networks and telehealth platforms, and event-driven presence at French healthcare conferences (SantExpo, SFAR).

Posos reports deployment at 300+ healthcare establishments and 90,000+ healthcare professionals across France, Belgium, and Luxembourg, via 15+ medical software editor partners including Equasens, Corilus, Bow Medical, InterSystems, Dedalus, Softway Medical, Tessan, Evolucare, and Orisha. The company has raised approximately €19.8M in cumulative funding (2019 seed, 2022 Series A, 2025 round) from investors including AG2R La Mondiale, Anaxago, Nord France Amorçage, Sofiouest, and Caisse des Dépôts. Notable strategic positions include a 2026 integration into the Corti Agentic Framework and a roadmap entry into personalized care plan generation.

Name

Posos

Legal name

POSOS SAS

Website

https://posos.co

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Posos is a French medtech company that operates a CE Class IIb certified AI platform for medication prescription decision support, serving medical software editors, hospitals, pharmacies, and individual practitioners across France, Belgium, and Luxembourg via APIs, embedded modules, and a freemium SaaS.

Ownership category

akta.pro rank

Headquarters

HQ city

Amiens

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Freemium + Premium Subscription (B2C): Basic "Offre basique" provided free of charge; "Offre premium" paid subscription for advanced features (DDI Predictor cytochromatic interactions, anticholinergic load, renal/hepatic dosage, equivalences across 8 therapeutic classes, scan d'ordonnances). 3-month free trial of premium, then annual subscription paid by credit card via Stripe. Auto-renewing period-based contract (any started period due in full).
2. B2B API & Software Licensing (Éditeurs de logiciels): Recurring B2B licensing of CE IIb certified APIs (transcription, risk analysis, medication database) to medical software editors who embed Posos into their EHR/LAP solutions. Custom quote-based pricing ("Sur devis") with automatic updates and personalized onboarding.
3. Enterprise Hospital Contracts: Custom-tailored ("Sur devis") annual enterprise contracts for healthcare establishments (hôpitaux, cliniques, EHPADs) covering three modules: (1) productivity augmentation through automatic retranscription, (2) therapeutic decision support, (3) complete medication reconciliation — typically integrated with the establishment's DPI/GAM.
4. Professional Services & Training: Included with enterprise contracts: "Formation de vos personnels soignants à l'utilisation et au pilotage de la solution" — onboarding and training services for hospital teams, plus reactive customer support including pharmacists for technical and clinical questions.

Pricing tiers

Go-to-market motion6 records

Distribution channels1 record

Marketing channels8 records

Core offering

Posos provides a CE IIb certified, ISO 13485 compliant AI medical platform that combines a drug knowledge graph, hybrid NLP and Computer Vision APIs for prescription transcription and clinical data structuring, and contextualized drug risk analysis. The platform is sold as a B2B API suite (FHIR, CDS Hooks, GraphQL) to medical software editors and as an enterprise solution to hospitals, with a freemium B2C mobile app for individual practitioners.

Product overview

Posos offers a single, unified, CE class IIb-certified AI platform for medical prescription that combines an interconnected drug knowledge graph, hybrid NLP/CV structuring APIs, intelligent prescription transcription, contextualized drug risk analysis, and plug-and-play agents for partner software editors. The platform is composed of: (1) the Posos Drug Database (base de données médicamenteuse), the AI-built, HAS-approved multilingual structured drug reference; (2) the Intelligent Prescription Transcription module ("Scan & Go" / e-scan d'ordonnances / IA de standardisation SNOMED) for OCR and structuring of paper/PDF/voice prescriptions into SNOMED-CT/FHIR/ICD-10/11 data; (3) the Drug Risk Analysis module (Analyse des risques iatrogènes) for personalized interaction, contraindication, dosage and therapeutic-alternative recommendations; (4) Posos APIs (GraphQL/FHIR/CDS Hooks) for medical software editors and agentic AI developers; (5) the Conciliation médicamenteuse (medication reconciliation) module for hospital admissions; (6) the Bilans de médication / Entretiens pharmaceutiques solutions for retail pharmacy; (7) Mobile apps (iOS/Android) for individual practitioners. The platform is designed for two integration modes — APIs for teams building their own AI agents, and ready-to-deploy widgets (Prêt à l'emploi) for faster time-to-market. Certified ISO 13485, CE IIb, HDS-hosted, with French/Belgian/Luxembourg coverage and FDA-readiness.

Differentiator

Problem solved

Functional benefit

Named customers11 records

Segments8 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration26 records

AI capability13 records

Feature8 records

Partnerships

22 partnerships are on record, tiered core and flagship.

• SemblecoreStrategic or Co-development Partner · 19 May 2026Semble (UK-based medical software leader) confirmed its commitment to the French market and obtained Ségur Numérique vague 1 and LAP HAS v2 certifications with Posos — partnership enables Semble's compliance in France.
• OkeirocoreStrategic or Co-development Partner · 19 May 2026Okeiro (precision medicine platform for transplant and chronic kidney disease patients) integrated Posos' AI-assisted prescription technology to secure and facilitate the medication journey of transplant and CKD patients.
• CortiflagshipStrategic or Co-development Partner · 19 May 2026Posos joined the Corti Agentic Framework as an Expert on medications and prescription assistance, announced at SantExpo 2026. Posos is one of the first Experts integrated into Corti's multi-agent platform launched February 2026 — any AI agent built on Corti can now rely on Posos' medication data and CE IIb certified prescription algorithms.
• NEHS DigitalcoreTechnology or Integration · 22 September 2025NEHS Digital and Posos combine forces to offer optimized time management for anesthesiologists and emergency physicians — interview with Jean-Louis Baudet (NEHS Digital) and Emmanuel Bilbault (Posos) on the partnership.
• EvolucarecoreTechnology or Integration · 22 September 2025Evolucare and Posos concluded a partnership to simplify the work of anesthesiologists — Posos e-scan and prescription support integrated into Evolucare's anesthesia software suite.
• Groupe EquasensflagshipStrategic or Co-development Partner · 22 September 2025Le Groupe Equasens and Posos partner to transform pharmacy dispensing with innovative AI — also reported by MarketScreener on 2024-11-21 as a 'strategic partnership in AI'. Equasens is one of France's leading pharmacy software groups.
• CorilusflagshipOEM/ Whitelabel/ Licensing Partner · 22 September 2025Corilus chose Posos to provide new-generation clinical assistance to prescribers in Belgium and France. Corilus integrates Posos into CareConnect and Softalmo: 'Avec Posos, nous intégrons une assistance clinique de référence au cœur de CareConnect et de Softalmo.' Represents a new standard of prescription in Corilus products.
• GiropharmcoreChannel Partner/ Reseller/ Distributor · 22 September 2025Giropharm partnered with Posos to support its member pharmacists in carrying out their new clinical missions (entretiens pharmaceutiques, bilans partagés de médication) at the pharmacy counter.
• Bow MedicalflagshipTechnology or Integration · 18 September 2025Strategic expansion announced at SFAR 2025: Bow Medical deploys Posos' "Scan & Go" intelligent prescription re-entry module across its entire product range, including the Diane Consult online anesthesia consultation solution. The AI module automatically recognizes and transcribes patient treatments from photographed or scanned prescriptions, eliminating up to 1.5 hours of manual data entry per day. The integration covers 450+ healthcare facilities and potentially impacts 5+ million annual anesthesia consultations, marking a step toward AI-augmented medical practice in anesthesia.
• Arche MC2coreStrategic or Co-development Partner · 12 June 2025Posos and Arche MC2 (major editor of software for social, medico-social, and healthcare sectors) automate prescription entry in HAD (Hospitalisation À Domicile) — integrating Posos' e-scan prescription technology directly into Arche MC2's AtHome software, the reference solution for HAD. Marks a turning point in HAD care processes.
• Orisha Socialcare (ex Teranga Software)coreTechnology or Integration · 21 May 2025Orisha Socialcare integrates Posos' e-scan prescription module into NETSoins and NETVie to strengthen the security of treatments in EHPADs and specialized medical establishments (MAS, FAM). Originally announced May 2025.
• InterSystemsflagshipStrategic or Co-development Partner · 4 February 2025Reinforced technological alliance to accelerate and secure AI-assisted drug prescription worldwide. Posos integrates with InterSystems TrakCare (used at Centre Hospitalier de la Côte Basque) — combining Posos' clinical AI APIs with InterSystems' global EHR platform to enable secure AI-driven prescribing across international markets.
• Ouest-FranceflagshipGTM or Marketing Partner · 1 February 2025GTM/content partnership with Ouest-France (major French regional daily newspaper) to launch the Ouest-France Santé health thematic channel. Posos powers the medication glossary, pathologies, and content for Ouest-France Santé readers — providing verified medical information to the general public.
• MediprixcoreChannel Partner/ Reseller/ Distributor · 1 January 2025Posos and Mediprix partnership serving the clinical pharmacist — supports Mediprix-affiliated pharmacists in their new clinical missions via Posos platform.
• TessancoreOEM/ Whitelabel/ Licensing Partner · 22 September 2024Tessan (télémédecine) integrated Posos into its medical software to equip its doctors with simple, reliable, and compliant prescription tools. Quote from Jordan Cohen, CEO Tessan, featured on the Posos homepage. Tessan joins the Posos partner logo wall.
• QarecoreTechnology or Integration · 1 May 2024Qare (major French teleconsultation platform) proposed innovative and personalized teleconsultation by partnering with Posos for prescription assistance for physicians.
• ViatriscoreStrategic or Co-development Partner · 1 May 2024Posos and Viatris pursue their collaboration around a new shared medication reconciliation (bilan partagé de médication) solution to free the pharmacist from administrative load and dedicate more time to patient relationships.
• RofimcoreTechnology or Integration · 1 April 2024Posos and Rofim partnered to offer a complete and innovative solution to French Cancer Treatment Centers (CLCC — Centres de Lutte Contre le Cancer) to improve diagnosis and patient care management in oncology.
• Alphega PharmaciecoreChannel Partner/ Reseller/ Distributor · 1 February 2024Posos launched its medication reconciliation (bilan de médication) solution and partnered with Alphega Pharmacie to develop new patient services in retail pharmacies.
• MHCommcoreStrategic or Co-development Partner · 1 October 2023MHComm and Posos formed a strategic partnership — major advance for the digitization of prescriptions in HAD (hospital-at-home).
• Softway MedicalcoreTechnology or Integration · 1 November 2022Softway Medical integrated Posos into its Hopital Manager hospital software — enabling prescription safety features for Softway's hospital customers in France.
• DedalusflagshipTechnology or Integration · 1 May 2021SantExpo 2021 — A first in prescription assistance in hospitals with Dedalus and Posos. Dedalus is one of Europe's largest hospital software vendors; Posos is embedded in their hospital EHR suites.

Scale indicators16 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Wolters Kluwer Clinical Drug Information (Lexicomp/Medi-Span): Wolters Kluwer's Clinical Drug Information division offers Lexicomp and Medi-Span drug databases used by hospitals and EHRs for drug interaction, dosing, and clinical decision support. Direct peer to Posos' drug database and risk analysis API; larger and globally established with deeper hospital penetration.
• First Databank (FDB): FDB (owned by Hearst) provides drug databases (FDB MedKnowledge) and clinical decision support embedded in major US EHRs. Direct competitor in the structured drug knowledge / API-for-software-editors space; primarily US-focused but increasingly global.
• DrFirst: DrFirst offers medication management, e-prescribing, drug interaction checking, and clinical workflow APIs used by hospitals, EHRs, and pharmacies. Comparable to Posos' prescription safety and risk analysis APIs; US-based with similar B2B-to-software-editor GTM.
• Corti: Corti builds the Agentic Framework for clinical AI workflows, launched February 2026, into which Posos was integrated as a drug/prescription Expert. Comparable AI-platform-for-clinicians offering with overlapping customer base (hospitals, telehealth), though focused on ambient conversation/intake rather than drug safety.

Broad incumbents

• Elsevier Clinical Solutions (ClinicalKey/Gold Standard): Elsevier's Clinical Solutions includes drug databases (Gold Standard), ClinicalPath decision support, and ClinicalKey reference platform embedded across global hospital systems. Broad incumbent with overlapping drug database capabilities but a much wider portfolio beyond prescription safety.
• Oracle Health (Cerner Multum): Oracle Health (formerly Cerner) bundles the Multum drug database and clinical decision support within its dominant EHR installed base. Massive global incumbent; competes with Posos at the hospital EHR layer and increasingly partners/competes via its own drug database.

Emerging players

• Suki AI: Suki AI offers an AI voice assistant for clinicians that automates documentation, coding, and point-of-care queries including drug information. Emerging AI assistant for clinicians — partial overlap with Posos' individual practitioner product, though focused on ambient documentation rather than drug safety.
• Nabla: Nabla is an AI ambient scribe and clinical assistant for physicians, expanding into broader clinical decision support. Partial overlap with Posos' individual clinician product; both target AI-augmented prescribing workflows but Nabla leads with documentation.
• Abridge: Abridge is a medical conversation AI platform that structures patient-clinician dialogue into clinical notes, codes, and orders. Comparable AI-for-clinicians GTM with hospital system integrations; potential partner or competitor as it expands into order entry and prescription workflows.
• Infermedica: Infermedica builds AI-powered symptom checking, triage, and preliminary diagnosis tools used by insurers, telehealth, and hospital systems. Adjacent clinical decision support category with API-first delivery; Europe-based (Poland) and comparable scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/posos_tech

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Posos